NVCR Similar Chart Price Prediction
The price of NVCR is predicted to go up 2.13%, based on the high correlation periods with HURC. The similarity of these two price pattern on the periods is 98.14%.
NVCR
HURC
Up: 2.13%Similarity: 98.14%
NVCR Revenue Forecast
NVCR EPS Forecast
NVCR FAQs
What is bull’s view on NVCR?
What is bear's view on NVCR?
What is NVCR revenue forecast for next quarter？
What is NVCR eps forecast for next quarter？
NVCR Analyst's Forecast
Jason Bednar
Piper Sandler
Buy
2024-12-13
Price Target
$28 → $42
Upside
+25.71%
Piper Sandler raised the firm's price target on Novocure to $42 from $28 and keeps an Overweight rating on the shares. The firm thinks the catalyst path for Novocure shares screens more favorably for medical technology investors that can better handicap upcoming "medtech-like" milestones for the company, including new indication commercialization, regulatory submission and approvals, and securing payer coverage. Piper introduced estimates through 2028 and highlights the company's improved execution for four consecutive quarters.
Vijay Kumar
Evercore ISI Group
Hold → Buy
2024-12-02
Price Target
$18 → $30
Upside
+0.5%
Vijay Kumar
Evercore ISI Group
Hold
2024-10-01
Price Target
$21 → $18
Upside
+20.89%
